Cigna's rising dividend, buybacks, and strong balance sheet offer an attractive risk/reward profile for investors. Read more ...

Medicare spending on “skin substitutes” made of dried placenta has soared as doctors pocket lucrative discounts from sellers.

Shares of Cigna Group CI rose 1.96% to $319.99 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 9.52% to 5,456.90 and the ...

Mizuho raised the firm’s price target on Cigna (CI) to $384 from $360 and keeps an Outperform rating on the shares. The firm surveyed 215 ...

Guggenheim initiated coverage of Cigna (CI) with a Buy rating and $384 price target The firm launched coverage on 11 healthcare services ...

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.

Cigna just handed over the Medicare keys to HCSC for a cool $3.3 billion, proving sometimes less is more—especially in healthcare. The sale includes Medicare Advantage, Medicare Part D, CareAllies, ...

T he Cigna Group has completed the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC ...

Cigna is a coverage provider that offers Medicare supplemental insurance and Medicare Advantage plans for adults over 65. Its website has a quote tool to help you estimate your rates, and many of ...